Physicians' Academy for Cardiovascular Education

Giving NOAC treatment at myocardial injury after non-cardiac surgery lowers major vascular complications

3' education - Mar. 11, 2018 - ACC 2018, Orlando, FL, USA - P.J. Devereaux - Hamilton, ON, Canada

ACC 2018 The MANAGE trial studied the effect of dabigatran in patients with myocardial injury after non-cardiac surgery. After a mean of 16 months follow-up, a relative risk reduction of 28% in major vascular complications was seen.

Educational information

This 3-minute education provides a summary of just presented scientific data, recorded during the ACC 2018. The objective is to provide a brief commentary and potential implications of these findings.


P.J. Devereaux is director of the division of Cardiology, at McMaster University, in Hamilton, ON, Canada


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.

Read more about the results of the MANAGE trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: